EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment

Pedro Ribeiro-Santos, Carolina Martins Vieira, Gilson Gabriel Viana Veloso, Giovanna Vieira Giannecchini, Martina Parenza Arenhardt, Larissa Müller Gomes, Pedro Zanuncio, Flávio Silva Brandão iD, Angélica Nogueira-Rodrigues iD

International Journal of Molecular Sciences · 15.07.2024 · 25 (14) · 7742

DOI: 10.3390/ijms25147742 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2024. Verfasst von Pedro Ribeiro-Santos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oncoclínicas&Co-Medica Scientia Innovation Research (MEDSIR), São Paulo 04542-390, Brazil. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Microsatellite Instability, Biomarkers, Tumor. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) is a heterogeneous disease with a rising incidence worldwide. The understanding of its molecular pathways has evolved substantially since The Cancer Genome Atlas (TCGA) stratified endometrial cancer into four subgroups regarding molecular features: POLE ultra-mutated, microsatellite instability (MSI) hypermutated, copy-number high with TP53 mutations, and copy-number low with microsatellite stability, also known as nonspecific molecular subtype (NSMP). More recently, the International Federation of Gynecology and Obstetrics (FIGO) updated their staging classification to include information about POLE mutation and p53 status, as the prognosis differs according to these characteristics. Other biomarkers are being identified and their prognostic and predictive role in response to therapies are being evaluated. However, the incorporation of molecular aspects into treatment decision-making is challenging. This review explores the available data and future directions on tailoring treatment based on molecular subtypes, alongside the challenges associated with their testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsMicrosatellite InstabilityBiomarkers, TumorHumansFemaleMutationPathology, MolecularPrognosisTumor Suppressor Protein p53

Stichwörter der Autor:innen

endometrial cancerlocal treatmentmolecular pathologyprecision medicinesystemic therapies

Substanzen

Biomarkers, TumorTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Oncoclínicas&Co-Medica Scientia Innovation Research (MEDSIR), São Paulo 04542-390, Brazil.
  • Brazilian Group of Gynecologic Oncology (EVA), Rio de Janeiro 35500-025, Brazil.
  • Department of Oncology, Santa Casa de Belo Horizonte, Belo Horizonte 30150-221, Brazil.
  • Department of Radiotherapy, Hospital Beneficência Portuguesa de São Paulo, São Paulo 01323-001, Brazil.
  • Department of Medicine, Federal University of Minas Gerais-UFMG, Belo Horizonte 30130-100, Brazil.
  • DOM Oncologia, Belo Horizonte 30190-111, Brazil.

ORCID-Profile: Flávio Silva Brandão, Angélica Nogueira-Rodrigues

Zitieren

APA

Ribeiro-Santos, P., Martins Vieira, C., Viana Veloso, G. G., Vieira Giannecchini, G., Parenza Arenhardt, M., Müller Gomes, L., Zanuncio, P., Silva Brandão, F., & Nogueira-Rodrigues, A. (2024). Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment. International Journal of Molecular Sciences, 25(14), 7742. https://doi.org/10.3390/ijms25147742

Vancouver

Ribeiro-Santos P, Martins Vieira C, Viana Veloso GG, Vieira Giannecchini G, Parenza Arenhardt M, Müller Gomes L, et al. Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment. International Journal of Molecular Sciences. 2024;25(14):7742. doi:10.3390/ijms25147742

BibTeX
@article{RibeiroSantos2024,
  author = {Ribeiro-Santos, Pedro and Martins Vieira, Carolina and Viana Veloso, Gilson Gabriel and Vieira Giannecchini, Giovanna and Parenza Arenhardt, Martina and Müller Gomes, Larissa and Zanuncio, Pedro and Silva Brandão, Flávio and Nogueira-Rodrigues, Angélica},
  title = {Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {14},
  pages = {7742},
  doi = {10.3390/ijms25147742}
}
Kostenlos starten →